✦ LIBER ✦
220 POSTER Combination of class I PI3K inhibitor, GDC-0941, with standard of care therapeutics results in enhanced anti-tumor responses in human cancer models in vitro and in vivo
✍ Scribed by D. Sampath; M. Belvin; J. Guan; K. Edgar; J. Wallin; W.W. Prior; R. Kassees; P. Moore; S. Patel; L. Friedman
- Book ID
- 119599375
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 74 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.